ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Wisconsin » Endocrinology, Diabetes Metabolism

Top Endocrinology, Diabetes Metabolism Prescribers in Wisconsin

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
RAJEEV JAIN M.D.

Endocrinology, Diabetes Metabolism

11,081

$1.12M

617
480 are 65+

2%
patients receiving schedule two controlled substances

Avg: 0%

5%
patients receiving schedule three controlled substances

Avg: 2%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

37%
prescriptions for brand name drugs

Avg: 50%

$102
Average prescription price

Avg: $158

MITCHELL JACOBSON M.D.

Endocrinology, Diabetes Metabolism

5,521

$716K

302
251 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

5%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

58%
prescriptions for brand name drugs

Avg: 50%

$130
Average prescription price

Avg: $158

ODETTE MORGAN MD

Endocrinology, Diabetes Metabolism

5,094

$1.02M

301
163 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

49%
prescriptions for brand name drugs

Avg: 50%

$201
Average prescription price

Avg: $158

ARNOLD ASP MD

Endocrinology, Diabetes Metabolism

4,673

$561K

300
232 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

42%
prescriptions for brand name drugs

Avg: 50%

$120
Average prescription price

Avg: $158

ELIZABETH NORA MD

Endocrinology, Diabetes Metabolism

3,820

$419K

376
255 are 65+

3%
patients receiving schedule two controlled substances

Avg: 0%

8%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

33%
prescriptions for brand name drugs

Avg: 50%

$110
Average prescription price

Avg: $158

MICHAEL SHEEHAN MD

Endocrinology, Diabetes Metabolism

3,790

$878K

325
188 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

4%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

56%
prescriptions for brand name drugs

Avg: 50%

$232
Average prescription price

Avg: $158

LAURA ANDREWS MD

Endocrinology, Diabetes Metabolism

3,509

$552K

364
242 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

5%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

50%
prescriptions for brand name drugs

Avg: 50%

$157
Average prescription price

Avg: $158

RICHARD WEIRICH MD

Endocrinology, Diabetes Metabolism

3,466

$527K

365
224 are 65+

3%
patients receiving schedule two controlled substances

Avg: 0%

4%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

44%
prescriptions for brand name drugs

Avg: 50%

$152
Average prescription price

Avg: $158

DIANE ELSON MD

Endocrinology, Diabetes Metabolism

3,345

$383K

211
147 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

8%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

48%
prescriptions for brand name drugs

Avg: 50%

$115
Average prescription price

Avg: $158

GREGORY PEHLING MD

Endocrinology, Diabetes Metabolism

3,161

$424K

230
162 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

41%
prescriptions for brand name drugs

Avg: 50%

$134
Average prescription price

Avg: $158

PAUL BEKX MD

Endocrinology, Diabetes Metabolism

3,026

$561K

244
146 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

49%
prescriptions for brand name drugs

Avg: 50%

$185
Average prescription price

Avg: $158

HAK-JOONG KIM M.D.

Endocrinology, Diabetes Metabolism

3,010

$335K

200
138 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

7%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

36%
prescriptions for brand name drugs

Avg: 50%

$111
Average prescription price

Avg: $158

KENT RAY DO

Endocrinology, Diabetes Metabolism

2,968

$542K

260
144 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

6%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

46%
prescriptions for brand name drugs

Avg: 50%

$183
Average prescription price

Avg: $158

MELISSA MEREDITH MD

Endocrinology, Diabetes Metabolism

2,635

$407K

199
121 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

55%
prescriptions for brand name drugs

Avg: 50%

$154
Average prescription price

Avg: $158

ALAN MCKENZIE MD

Endocrinology, Diabetes Metabolism

2,574

$455K

336
225 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

4%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

48%
prescriptions for brand name drugs

Avg: 50%

$177
Average prescription price

Avg: $158

JOHN CARROLL MD

Endocrinology, Diabetes Metabolism

2,477

$425K

274
187 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

4%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

66%
prescriptions for brand name drugs

Avg: 50%

$171
Average prescription price

Avg: $158

GAYLE KASDORF M.D.

Endocrinology, Diabetes Metabolism

2,425

$459K

244
175 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

54%
prescriptions for brand name drugs

Avg: 50%

$189
Average prescription price

Avg: $158

STEVEN RABINOWE M.D.

Endocrinology, Diabetes Metabolism

2,285

$491K

255
205 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

56%
prescriptions for brand name drugs

Avg: 50%

$215
Average prescription price

Avg: $158

DANIEL SHORT MD

Endocrinology, Diabetes Metabolism

2,267

$353K

157
102 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

47%
prescriptions for brand name drugs

Avg: 50%

$156
Average prescription price

Avg: $158

THOMAS KELLY M.D.

Endocrinology, Diabetes Metabolism

2,254

$296K

207
140 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

46%
prescriptions for brand name drugs

Avg: 50%

$132
Average prescription price

Avg: $158

BHAVIN SHASTRI MD

Endocrinology, Diabetes Metabolism

2,239

$409K

199
158 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

57%
prescriptions for brand name drugs

Avg: 50%

$182
Average prescription price

Avg: $158

SYED GARDEZI MD

Endocrinology, Diabetes Metabolism

2,192

$321K

218
127 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

54%
prescriptions for brand name drugs

Avg: 50%

$147
Average prescription price

Avg: $158

PAMELA BAETEN M.D.

Endocrinology, Diabetes Metabolism

2,170

$445K

230
157 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

56%
prescriptions for brand name drugs

Avg: 50%

$205
Average prescription price

Avg: $158

ESHRAQ AL-JAGHBEER MD

Endocrinology, Diabetes Metabolism

2,154

$332K

226
122 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

53%
prescriptions for brand name drugs

Avg: 50%

$154
Average prescription price

Avg: $158

CHARLES BINGHAM MD

Endocrinology, Diabetes Metabolism

2,140

$357K

244
162 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

53%
prescriptions for brand name drugs

Avg: 50%

$167
Average prescription price

Avg: $158

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank